Results 91 to 100 of about 58,197 (250)
Peptic Ulcer: An Infectious Disease?
Annals of Medicine, 1993 Since the ingestion studies by Marshall and Morris, Helicobacter pylori has been known to cause both acute and chronic infection in the human stomach activating both the cellular and the humoral immune system. It is of little or no value to evaluate the causative relationship of an infectious agent using Koch's criteria.
L P, Andersen, H, Nielsen
openaire +2 more sources
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection [PDF]
, 1998 In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection.
Miehlke, Stephan +11 more
core +1 more source
Integrative Zoology, EarlyView.This study assessed the probiotic potential of intestinal microbiomes from five snake species using metagenomics and in vitro isolation, identifying two promising strains (Lactobacillus johnsonii DA0116 and Limosilactobacillus reuteri DA0218) through comprehensive screening.
Xuena Kang +11 more
wiley +1 more source
Transcranial electrical stimulation in the treatment of peptic ulcer
Лечащий ВрачBackground. Peptic ulcer disease is a chronic polyethological disease that occurs with the formation of ulcerative lesions, a tendency to progression and the formation of complications.
Dariya N. Tarasova +2 more
doaj +1 more source
Allergy, EarlyView.ABSTRACT Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare and potentially life‐threatening systemic, inflammatory disease with multi‐organ manifestations, variable presentation and complex pathology. Multiple interconnected immunological pathways are implicated in EGPA pathology, including a type‐2 immune response driving predominantly ...
Harold Wilson‐Morkeh +7 more
wiley +1 more source
Medicinal plants with gastroprotective potential
Bangladesh Journal of Pharmacology, 2015 Peptic ulcer disease (PUD) is a main source of morbidity and mortality worldwide. It is characterized by erosions in mucosal linings of stomach and duodenum.
Wafa Majeed +4 more
doaj
ANZ Journal of Surgery, EarlyView.ABSTRACT Background Peptic ulcer disease (PUD) continues to be a health issue, mainly due to Helicobacter pylori (H. pylori) infection and non‐steroidal anti‐inflammatory drugs (NSAIDs). Despite better treatment of H. pylori and use of proton pump inhibitors, the rate of reduction in PUD complications is slowing down.
Vidya Willis +3 more
wiley +1 more source
Past, present and future of surgical treatment of peptic ulcer (50-year experience of the institute)
Gastroenterologìa, 2017 The article presents the literature data and the results of the author’s own research on the development of peptic ulcer surgery in the historical aspect.
B.F. Shevchenko +4 more
doaj +1 more source
Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
British Journal of Pharmacology, EarlyView.Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman +3 more
wiley +1 more source
Effect of Medication Intake on Dental Implant‐Related Outcomes—A Scoping Review
Clinical Oral Implants Research, EarlyView.ABSTRACT Objective The objective of this scoping review was to evaluate the effect of systemic medications on dental implant outcomes in medically compromised patients. Material and Methods Electronic and manual searches were conducted for this scoping review.
Alberto Monje +4 more
wiley +1 more source